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Background: Obesity is a growing health concern in Kuwait. Obesity has been identified as a key risk factor for
many chronic diseases including hypertension, dyslipidemia and type 2 diabetes mellitus. It has been shown that
community pharmacists' involvement is associated with successful weight management in developed countries.
This study was conducted to investigate the role of community pharmacists in obesity counseling, and to identify
the barriers to counseling in Kuwait.
Methods: A descriptive cross-sectional study involved 220 community pharmacies that were selected via stratified
and systematic random sampling. A pretested self-administered questionnaire collected information on frequency
and comfort level with obesity counseling, and the perceived effectiveness of four aspects of obesity management
(diet and exercise, prescribed antiobesity medications, diet foods, and nonprescription products and dietary
supplements). Information on perceived confidence in achieving positive outcomes as a result of counseling and
barriers to counseling was also collected. Descriptive and Spearman’ r analysis were conducted using SPSS version
17. Responses with Likert scale rating 1(low score) to 5 (high score) and binary choices (yes/no) were presented as
mean (SD) and (95% CI), respectively.
Results: The response rate was 93.6%. The overall mean (SD) responses indicated that pharmacists counseled obese
patients sometimes to most of the time, 3.67 (1.19) and were neutral to comfortable with counseling about aspects
of obesity management, 3.77 (1.19). Respondents perceived obesity management aspects to be somewhat effective,
3.80 (1.05). Of the four aspects of obesity management, diet and exercise, and diet foods were the highest ranked
in terms of frequency of counseling, comfort level and perceived effectiveness. Pharmacists were neutral to
confident in achieving positive outcomes as a result of obesity counseling, 3.44 (1.09). Overall mean responses of
counseling obese patients by pharmacists were positively correlated with their perceived comfort with counseling
and perceived effectiveness of obesity management aspects. The most anticipated barriers to obesity counseling
were lack of patient awareness about pharmacists' expertise in counseling 76.2% (95% CI: 69.7-81.7) and
pharmacists’ opinions that obese patients lack willpower and are non-adherent to weight reduction interventions
71.8% (95% CI: 65.1-77.8).
Conclusions: Strengths, weaknesses and barriers related to obesity counseling by pharmacists in Kuwait were
identified, and suggestions were provided to strengthen that role.
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Obesity and overweight represent a rapidly growing
public health challenge worldwide. World Health
Organization (WHO) estimates that 1.5 billion adults
and about 43 million children under 5 years old were
overweight in 2010. In general, greater than one in ten
of the world’s adult individuals are obese [1]. Obesity
and overweight are the fifth leading risk for worldwide
deaths [1]. Obesity is a risk factor for development of
various diseases including coronary heart disease, dysli-
pidaemia, hypertension, stroke, some forms of cancer,
type 2 diabetes mellitus, gallbladder disease, osteoarth-
ritis and gout, and pulmonary diseases, including sleep
apnoea [2].
In Kuwait, obesity is a growing health concern; several
studies have shown the high prevalence of overweight
and obesity among the population. In 2010, about 80%
of women were overweight or obese, and childhood
obesity continues to increase as well [3-6]. The most
common factors contributing to overweight and obesity
are overeating unhealthy high-fat foods and sedentary
lifestyles [6]. Thus, there is an urgent need for the imple-
mentation of effective preventive measures for control-
ling the prevalence of obesity including public education
about lifestyle modifications.
Barriers to the assessment and management of obesity
by physicians include inadequate training, lack of time,
lack of reimbursement, lack of access to dietician and
uncertainty in relation to the efficacy of weight loss
interventions [7]. Furthermore, the provision of diet
sheets and referral to a dietician or a psychotherapist by
physicians was found to be unsatisfactory by the obese
patients [8]. In 1989, the definition of health promotion
was expanded to emphasise the importance of cooper-
ation between different stakeholders to enhance aware-
ness, change behaviour and create environments that
support good health practices [9]. Among them, com-
munity pharmacists have a valuable role in promoting
and maintaining public health as one of the most access-
ible health care providers. Pharmacists have already
started working with other health care professionals in
the USA to maintain and promote public health [10]. A
study conducted across Europe shows that 64% out of a
total of over 6,000 people in six countries supported the
further development of community pharmacies as alter-
natives to physicians' clinics, so that they can have more
choice in receiving advice and treatment for common
conditions. The greatest support for extending pharmacy
based health care was in the United Kingdom (UK) and
Poland [11].
Health promotion plans focus on community based
interventions and partnerships to maintain wellness and
to help modify individual behaviours such as unhealthy
lifestyles [12]. In the UK and Australia, communitypharmacies are recognised as the most accessible
healthcare settings due to the high volume of the
population that use their services [13]. Given the nu-
merous comorbidities characteristically exist with obes-
ity, obese patients often interact with their community
pharmacists to obtain prescription drugs and/or over-
the-counter (OTC) products for these diseases. In fact,
pharmacist is the most accessible health care profes-
sional in the community who can help patients in the
management of overweight and obesity by assisting in
the selection of weight loss agents, offer appropriate
counseling on nutritional and lifestyle modifications,
and monitoring to ensure safe and effective pharmaco-
therapy outcomes [14-17]. A systematic review of
community pharmacy-based weight management inter-
ventions reported the findings of 10 relevant studies
conducted in the USA, the UK, Switzerland, Spain
and Denmark [18]. In England, pharmacist-led weight
management program has achieved significant results,
and its success was one of the major driving forces
behind the Department of Health’s recommendation
that community pharmacists should be involved in
weight management services [19].
Pharmacy associations, such as the American Society
of Health-System Pharmacists encourages pharmacists
to work with obese clients to reinforce lifestyle modifica-
tions and provide education and encouragement [20]. A
number of the pharmacy profession roles were identified
in a clinical guideline on the prevention and manage-
ment of obesity published by the National Institute for
Health and Clinical Excellence [21]. In developed coun-
tries, community pharmacists have been identified as
health advisors and highly credible source of health in-
formation to the general public through their counseling
activities, including helping clients achieve and maintain
a healthy weight [18,19,22-26].
In a country like Kuwait, where overweight and obesity
are prevalent, the contribution of all health care profes-
sionals including pharmacists in fighting this epidemic is
crucial. Most studies on the pharmacists’ role in obesity
counseling have been conducted in developed countries,
and there is a lack of information on this role in the
Middle East region including Kuwait. Therefore, the
present study was designed to describe the self-reported
practice of community pharmacists in relation to coun-
seling patients with obesity, identify the practice barriers
to obesity counseling as well as strategies to overcome
barriers to counseling.
Methods
A descriptive, cross-sectional survey was conducted in
Kuwait. Kuwait is a Middle Eastern country with an area
of 17.820 square kilometres and an estimated population
3.328.136 people (2007 estimate). The study population
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pharmacies in Kuwait. The ethical clearance for this study
was obtained from the "Human Ethical Committee,
Health Sciences Center, Kuwait University".
The sample size was determined using Java Applets
for Power and Sample Size [27]. It was calculated that a
sample size of 186 pharmacists would be required to de-
termine a 20% difference in proportion between two
groups (e.g., male vs. female) with an 80% power and a
5% significance level. The community pharmacies’ lists
at different governorates were obtained from the Minis-
try of Health (current at the time of the study) for sam-
ple selection, due to the lack of lists with the names and
addresses of community pharmacists in Kuwait. A larger
sample of 220 community pharmacies (out of a total of
287) was selected to adjust for possible nonresponse,
using stratified and systematic random sampling accord-
ing to the methodology described by World Health
Organization [28]. The stratification was at the level of
the five governorates of Kuwait (Capital, Al-Ahmadi,
Al-Farwaniyah, Hawalli and Al-Jahra). A pharmacy employ-
ing more than one registered pharmacist, only one was
included.
The basis of developing the study questionnaire was
obtained from validated surveys that investigated com-
munity pharmacists’ counseling on obesity management
and barriers to obesity counseling in the USA [29,30].
The original surveys remained unchanged except for few
items that were not applicable to pharmacists in Kuwait.
The questionnaire contained both closed and open-
ended questions. It was pretested for content, design,
readability, and comprehension on 15 community phar-
macists and modifications were made as necessary so
that the questionnaire was simple to answer, yet gave ac-
curate data. Demographic and other characteristics data
collected included gender, age, basic and postgraduate
qualifications, years practiced as a pharmacist and loca-
tion of the pharmacy. Pharmacists were asked about
how often they counseled patients regarding four aspects
of obesity management: diet and exercise, prescribed
antiobesity medications, diet foods, and nonprescription
products and dietary supplements for weight loss.
Responses were measured on a 5-point Likert scale
(never [1], rarely [2], sometimes [3], most of the time
[4], always [5]). Pharmacists' comfort level with counsel-
ing about the four aspects of obesity management was
measured by a 5-point Likert scale (extremely uncom-
fortable [1], uncomfortable [2], neither comfortable nor
uncomfortable [3], comfortable [4] extremely comfort-
able [5]). A 5-point Likert scale (extremely ineffective
[1], ineffective [2], neither effective nor ineffective [3], ef-
fective [4], extremely effective [5]) was used to measure
the respondents’ perceived effectiveness of the four
aspects of obesity management. The extent to whichpharmacists perceived confident in achieving positive
outcomes as a result of counseling obese patients was
measured by listing seven obesity management related
items and asking respondents to indicate on a 5-point
scale (extremely unconfident [1], unconfident [2], nei-
ther confident nor unconfident [3], confident [4], ex-
tremely confident [5]). The barriers that can limit
pharmacists’ participation in counseling obese patients
was measured by listing ten barriers, and asking respon-
dents to indicate yes or no on each barrier. A 4-point
Likert scale (not at all [1]; not very much [2]; to some
extent [3]; to a great extent [4]) was used to measure the
opinions of the respondents in relation to eight strat-
egies that can help to overcome the barriers.
On approaching a pharmacy, four data collectors
(pharmacists) briefly explained the purpose of the study
to the community pharmacist on duty (face-to face).
Pharmacists were free to refuse to participate in the sur-
vey. Those who agreed to take part in the study were
given the questionnaires and then were collected from
them anonymously after being completed within 1–2
weeks. They were assured for confidentiality and gave
written consent to participate in the study. Incentives
were not offered for completion of the questionnaire.Statistical analysis
Data were entered into the Statistical Package for Social
Sciences (SPSS, version 17) and descriptive analysis con-
ducted. Pharmacists’ responses were presented as means
Likert scale rating (standard deviations) and percentages
(95% confidence intervals). The confidence intervals
were computed using EpiCalc 2000 (Brixton Health
website). Student t tests were used to evaluate the differ-
ences in means between two groups of the independent
variables (gender: males vs. females, age: 20–40 years vs.
41–60 years and experience as practitioners: ≤ 10 years
vs. > 10 years). Statistical correlational analysis (Spear-
man’s r) was used to measure the association between
respondents’ frequency of counselling and their comfort
level with counseling, frequency of counselling and per-
ceived effectiveness of aspects of obesity management;
and frequency of counselling and perceived confidence
in achieving positive outcomes. P < 0.05 was considered
statistically significant.Results
Study population
Two hundred and twenty pharmacists were approached
regarding study participation, 206 of whom agreed to
participate (93.6%). The mean (SD) age and experience
as practitioners of the study participants were 33.5 (6.5)
years and 9.5 (6.0) years, respectively. Table 1 shows the
characteristics of respondents.









Basic qualification in pharmacy
B. Pharm 198 96.1
M. Pharm 5 2.4
Pharm D 3 1.5
Postgraduate qualification(s) in pharmacy
Diploma 15 7.3
Master degree 9 4.4
Experience as practitioners (Years)
≤ 10 150 72.8
> 10 56 27.2
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Table 2 shows the study participants’ responses regard-
ing the frequency, comfort and effectiveness of four
aspects of obesity management. The overall mean (SD)
responses indicated that the respondents counseled
patients sometimes to most of the time, 3.67 (1.19) and
were neutral to comfortable with counseling patients
about aspects of obesity management, 3.77 (1.19). Phar-
macists perceived obesity management aspects to be
somewhat effective in weight loss, 3.80 (1.05). Of theTable 2 Responses to the frequency, comfort and effectivene
Aspects of obesity Management *Frequency of
counseling
Mean (SD)
Diet and exercise 4.22 (1.06)
Diet foods 4.03 (0.99)
Prescribed anti-obesity medications 3.29 (1.23)
Non-prescribed anti-obesity products and
dietary supplements for weight loss
3.14 (1.09)
Overall Scale mean 3.67 (1.19)
*: Measured on a 5-point Likert scale: 1, never; 2, rarely; 3, sometimes; 4, most of th
^: Measured on a 5-point Likert scale: 1, extremely uncomfortable; 2, uncomfortable
comfortable.
#: Measured on a 5-point Likert scale: 1, extremely ineffective; 2, ineffective; 3, neithfour aspects of obesity management diet and exercise,
and diet foods were the highest ranked in terms of fre-
quency of counseling, comfort level and perceived effect-
iveness. Respondents were neutral to confident in
achieving positive outcomes as a result of obesity coun-
seling, 3.44 (1.09). Pharmacists were most confident in
achieving positive outcomes as a result of counseling
about exercise and diet (Table 3).
Respondents’ frequency of counseling was significantly
and positively associated with their comfort level with
counseling obese patients (r=0.80; p < 0.001). Higher
levels of perceived effectiveness of obesity management
aspects were also significantly associated with higher
levels of counseling obese patients (r=0.61; p < 0.001).
Pharmacists’ frequency of obesity counseling was not
significantly associated with their perceived confidence
in achieving positive outcomes as a result of counseling
(r=0.06; p = 0.07). There were no significant differences
among the respondents’ characteristics in relation to fre-
quency of counseling, comfort level and perceived effect-
iveness of options of obesity management (p > 0.05).
Females were more confident than males in achieving
positive outcomes in relation to patient adherence to
antiobesity medications (p = 0.003), nutritional advice
(p < 0.001), engagement in regular exercise (p = 0.02) and
eating a calorie-controlled diet (p=0.008).
Barriers to obesity counseling
Pharmacists indicated that the most anticipated barriers
to counseling obese patients were lack of patient aware-
ness about pharmacists' expertise in counseling 76.2%
(95% CI: 69.7-81.7), pharmacists’ opinions that obese
patients lack willpower and are non-adherent to weight
reduction interventions 71.8% (95% CI: 65.1-77.8), and
lack of pharmacists’ time 69.4% (95% CI: 62.6-75.5)
(Table 4).
Strategies to overcome barriers to obesity counseling
Pharmacists believed that increased awareness among







4.28 (1.19) 4.47 (0.83)
4.06 (0.98) 4.11 (0.94)
3.40 (1.05) 3.37 (0.65)
3.36 (1.29) 3.23 (1.27)
3.77 (1.19) 3.80 (1.05)
e time; 5, always.
; 3, neither comfortable nor uncomfortable; 4, comfortable; 5, extremely
er effective nor ineffective; 4, effective.; 5, extremely effective.
Table 3 Responses on perceived confidence in achieving
positive outcomes as a result of counseling patients with




Eating a calorie-controlled diet 3.75 (1.57)
Engagement in regular exercise 3.73 (1.27)
Patient adherence to nutritional advice 3.68 (1.27)
Proper use of nonprescription products and
dietary supplements for weight loss
3.59 (1.24)
Minimization of adverse effects from
anti-obesity medications
3.46 (1.37)
Patient adherence to anti-obesity medications 3.43 (1.35)
Proper handling of missed doses of
anti-obesity medications
3.21 (1.21)
Overall scale mean 3.44 (1.09)
Measured on a 5-point Likert scale: 1, extremely unconfident; 2, unconfident;
3, neither confident nor unconfident; 4, confident; 5, extremely confident.
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obesity and communication skills as the top three strat-
egies to overcome barriers to counseling (Table 5).
Discussion
Key findings
This is the first study to our knowledge to be conducted
in Kuwait, and probably in the Middle East region to de-
scribe the practice of community pharmacists in obesity
management, and to identify the barriers to obesity
counseling as well as strategies to overcome them. Over-
all, community pharmacists in Kuwait sometimes to
most of the time counseled obese patients and were neu-
tral to comfortable with counseling about obesity treat-
ment. They perceived obesity management options to be
somewhat effective in bringing about weight loss, butTable 4 Anticipated barriers to counseling obese patients
(n =206)
Barriers % (95%CI)
Lack of patient awareness about pharmacists'
expertise in counseling
76.2 ( 69.7-81.7)
Opinions about people with obesity (i.e., lack of
willpower and do not adhere to the
interventions to reduce their weight)
71.8 (65.1-77.8)
Lack of pharmacist time for counseling 69.4 (62.6-75.5)
Lack of pharmacists who are expertise in counseling 55.8 (48.8-62.7)
Lack of patient demand for counseling 53.4 (46.4-60.3)
Lack of privacy for counseling 52.4 (45.4-59.4)
Lack of pharmacist interest in counseling 49.5 (42.5-56.5)
Lack of repayment to the pharmacist for counseling 48.1 (41.1-55.1)
Belief that obesity is controllable without medications 45.1 (38.3-52.2)
Opinions about obesity as not a disease 40.5 (33.6-47.4)were neutral to confident in achieving positive outcomes
with counseling. Lack of patient awareness about phar-
macists' expertise in counseling was perceived to be the
major barrier limiting community pharmacists in obesity
counseling.
Frequency of counseling patients with obesity
The present results revealed that pharmacists sometimes
to most of the time counseled patients about various
aspects of obesity management. This is contrary to the
practice in the USA, where pharmacists rarely to some-
times counseled obese patients [29]. The involvement of
the respondents in obesity counseling is a positive find-
ing that needs to be encouraged to provide the appropri-
ate care to obese patients. It was reported that
community pharmacists are well positioned to provide
weight management advice to the public, and their in-
volvement is associated with successful weight loss [23-
26]. Respondents who claimed that they counseled most
of the time could have meant that they mostly counseled
when asked by patients for services with regard to
weight management, while others may have been pro-
active and perhaps offered weight management services
to patients. However, this was not measured in this
study, but it is more likely to be reactive than proactive;
since it was reported that the wide involvement of phar-
macists in drug dispensing duties, lack of time and lack
of patients’ trust in the pharmacist’s ability to provide
good health as key barriers to their active involvement
in health promotion [31].
The current results identified that the respondents’
frequency of counseling regarding each of the four man-
agement options of obesity was positively correlated with
their comfort level and perceived effectiveness of the
obesity interventions. The study participants counseled
most frequently about diet and exercise and diet foods,
but less frequently about prescription and non-
prescription antiobesity products compared to the USA
study, where prescribed antiobesity medications followed
by diet and exercise were found to be the most frequent
counseling interventions [29]. Similar findings were
reported by a pharmacy survey in Europe that 90% of
the pharmacists thought that guidance on healthy eating
should be provided; whilst 74% thought that they should
offer advice on drug therapy for weight loss [32].
Comfort level with obesity counseling
Respondents indicated a high comfort level with deliver-
ing lifestyle counseling, which have been perceived by
them as the most effective intervention. This a positive
finding since lifestyle modification has been considered
as the first-line treatment for weight reduction, and sig-
nificantly proved to reduce the incidence of type 2 dia-
betes compared to drug therapy with metformin [33].
Table 5 Responses on strategies to overcome barriers to
counseling patients with obesity (n=206)
Strategies to overcome barriers to counseling Mean (SD)
Increased public awareness about pharmacists'








Increased staffing in pharmacy 3.36 (1.20)
Greater support from pharmacy
management for counseling activities
3.33 (0.96)
Development of a positive outlook
toward patients with obesity
3.29 (1.08)
Reimbursement (repayment/
compensation) to the pharmacists
for counseling
3.06 (1.06)
Establishment of private consultation
areas in the pharmacy
2.98 (1.27)
Measured on 4 -point Likert scale: 1, not at all; 2, not very much; 3, to some
extent; 4, to a great extent.
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given specific training to enable them to provide appro-
priate dietary advice involving instruction on healthy
eating. Evidence shows that providing behavioural sup-
port to people increases the chance of successful weight
loss [34]. In Kuwait, pharmacists may also need to de-
liver weight management programs that include behav-
iour change strategies to increase individuals’s physical
activity levels, improve eating behaviour and the quality
of the individual’s diet. It is evident that these multi-
component interventions are the treatment of choice
[21].
Perceived effectiveness of obesity treatments
Of interest that the study participants perceived OTC
medications and dietary supplements as the least effect-
ive therapeutic modality. Despite the fact that many
pharmacists promote the use of dietary supplements and
herbals in their practice, some studies have shown that
pharmacists perceive them relatively less effective com-
pared to dietary changes and exercise for management
of obesity and coronary heart disease [30,35]. There is
currently insufficient scientific evidence to support the
use of OTC remedies for weight loss and to suggest that
they are safe. OTC products are potentially helpful al-
though likely yield no significant long-term weight loss.
They can have a very diverse unpredictable levels of
ingredients, and may be dangerous to the consumers’
health due to the toxicity of herbs used and herb-drug
interactions [36]. A serious problem with herbal antiobe-
sity remedies is the possibility that these products con-
tain adulterants in their ingredients like sibutramine and
thyroid extracts, which may have potential negativedrug-herb interactions [36]. Thus, pharmacists in Kuwait
need to be more involved in offering professional opin-
ion, counseling and/or monitoring obese patients who
are taking these antiobesity OTC products.
Confidence in achieving positive outcomes as a result of
obesity counseling
The present findings revealed that community pharma-
cists’ overall response with respect to their confidence in
achieving positive outcomes as a result of their counsel-
ing with obesity was neutral, which is similar to that
reported by the USA study [29]. However, unlike phar-
macists in the USA study, who were most confident
about achieving positive medication-related outcomes,
pharmacists in Kuwait were most confident about
achieving positive lifestyle-related outcomes. The less in-
volvement of the respondents in counseling about pre-
scription and non-prescription antiobesity products may
be explained by their neutral responses to comfort level
and effectiveness of both therapeutic interventions. This
may be due to their beliefs that these medications are
less effective compared to diet and exercise, and with
poor safety profiles. Furthermore, the low use of antio-
besity therapies in Kuwait compared to other countries
could be another contributing factor. In Kuwait, a study
was conducted to investigate the general practitioners’
attitudes and current practices in obesity management
showed that most of the respondents preferred not to
prescribe antiobesity medications [37].
Since counseling is one of the important aspects of
pharmaceutical care, our findings highlight the need for
pharmacists to be always involved in counseling patients
concerning prescribed antiobesity medications. They
should have a responsibility to counsel the patient before
dispensing the medication providing proper directions of
use, advice on missed doses, side effects and storage.
Appropriate pharmacists’ counseling on prescribed anti-
obesity medications was found to improve patients’ ad-
herence and achieve weight loss [23].
Barriers to obesity counseling
Lack of patient awareness about pharmacists' expertise
in counseling, pharmacists’ opinions that obese patients
lack willpower and non-adherent to weight reduction
interventions, and lack of pharmacists’ time were identi-
fied as the main barriers to obesity counseling. It was
reported that the public in Kuwait has a poor image of
pharmacists due to the limited interactions between
pharmacists and patients, which has resulted in lack of
recognition for pharmacy services by patients [38]. It
was found that patients will not accept care provided by
pharmacists for many reasons such as their unfamiliarity
with the pharmacists’ expertise, their concern about the
value of this service, and their belief that pharmacists
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rier can be overcome through the pharmacists’ beliefs in
their knowledge and skills, and the effective provision of
a pharmaceutical care practice with great confidence
that will convince patients of its value [39]. Education of
patients about the importance of health care, and the
role of pharmacists in providing counseling about health
promotion behaviours can help in increasing patient
awareness about the care that pharmacists can provide.
It is also crucial to generate the perception in the com-
munity that their local pharmacist is the logical first
source of health advice who will become a trusted ser-
vice provider to them individually.
The strategy that was perceived by respondents as hav-
ing the greatest impact on overcoming barriers to obes-
ity counseling was to create awareness among patients
about pharmacists' ability to counsel about obesity. Add-
itionally, pharmacists need to become better prepared
for these new roles. This can be achieved by the im-
provement of pharmacists’ knowledge about obesity and
communication skills as being indicated by respondents.
Similar findings were reported by a survey conducted in
six European countries that 96% of pharmacists believed
that with support and training they are well placed to
help persons with their weight loss efforts [11]. Hence, a
joint sustained collaboration between the Ministry of
Health, the Pharmaceutical and Medical Associations
and Kuwait University is essential to design and imple-
ment effective professional service training programs to-
wards sharpening pharmacists’ knowledge and practical
clinical skills to provide consistent, evidence based and
integrated healthcare system weight management ser-
vices. The strong cooperation between the professional
associations, faculty of pharmacy, continuing education
centers, and practicing pharmacists contributed effect-
ively in the development of community pharmacy ser-
vices [40]. Attention should also be given in the teaching
of undergraduate pharmacy students to ensure that they
are equipped with the knowledge and skills needed for
the roles of health promotion and disease prevention
[41].
Respondents’ beliefs that obese people lack will power
and do not adhere to weight loss interventions did not
negatively affect their frequency of counseling, which
signify that their personal biases have not interfered with
their counseling frequency.
The current results identified that lack of pharmacists’
time is one of the main barriers that needs to be over-
come. Lack of time is the most significant obstacle
standing against the implementation of nontraditional
roles of pharmacists worldwide [30,42-44]. Pharmacists
could make more time available if there is better delinea-
tion between the roles of the pharmacist and the techni-
cian. If pharmacists were less involved in dispensing andpreparation duties, this would “free-up” time for patient-
focused care [45]. It may be cost-effective to employ
more pharmacists if this will attract more customers by
extended services provided by pharmacists. This is con-
sistent with the fourth and fifth strategies identified by
this study to overcome barriers, which are increased
staffing in pharmacy and greater support from pharmacy
management for counseling activities.
Unlike pharmacists in previous studies [30,46], this
study showed that pharmacists did not indicate lack of
remuneration as one of the important perceived barriers
to obesity counseling. Lack of time as a main barrier in
this study may be due to that respondents would want
remuneration for something they see as an extra activity
since compensation is an issue for many pharmacists in
international studies. Pharmacists should be compen-
sated for providing substantial investment in knowledge,
skills and time for a service. If payments for counseling
were provided, then services would be more likely to be
provided, and pharmacists would be more proactive
[47].Strengths and limitations
The strength of this study is that we used appropriate
sampling method and sample size to generate a repre-
sentative data about the study population. Further
strength is the high response rate. The results can, there-
fore, be generalized at the study population level in
Kuwait. On a whole, this study fill in an important gap
in literature and provides useful piece of information for
obesity counseling by pharmacists in the Middle East.
We acknowledge that this type of study, using a self-
administered questionnaire, has its limitations. The in-
formation given by respondents may be influenced by
what is perceived to be the right answer to give. The ex-
tent of truthful answers or verifying respondents’ claims
is not possible in this type of study. A further limitation
of the study is the cross-sectional nature of the data that
represented one point in time and, therefore, do not re-
flect any changes in respondents’ beliefs over time in re-
lation to obesity. A final limitation was that responses of
the study participants may have depended on their abil-
ity to recall experiences with their patients.Future research
This study identified the perceived barriers to obesity
counseling by community pharmacists and provided
strategies to overcome them. Further research to eluci-
date in the understanding of barriers and facilitators will
help in the adoption and implementation of consistent,
evidence based and integrated healthcare system weight
management services in the community pharmacies of
Kuwait.
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Overall mean responses of counseling obese patients by
pharmacists were positively correlated with their per-
ceived comfort with counseling and perceived effective-
ness of obesity management aspects. Similarities as well
as differences in beliefs and practices were identified be-
tween pharmacists in Kuwait and those in developed
countries. Due to the high prevalence of overweight and
obesity among the population in Kuwait, there is a
greater need for pharmacist involvement in helping to
tackle this problem, than in many other developed coun-
tries where it is already happening.
The involvement of the respondents in obesity coun-
seling, in addition to their declaration of the perceived
barriers and strategies to overcome them would certainly
be an advantage to the provision of weight management
services in community pharmacies of Kuwait. Further-
more, pharmacists who effectively perform obesity coun-
seling need to be identified so that they may act as a
role model for others.
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